Iconovo strengthens the sales and business development organization to meet the increased customer demand and to launch the growing product portfolio. Roger Lassing will be part of the Iconovo’s management team and will be responsible for Business Development and Global Marketing. He will assume his position on March 1, 2019.
Roger Lassing has a Master of Science in Business and Economics and has extensive life science experience. Most recently, Roger comes from a Global Business Development role at Leo Pharma A/S. Prior to that, Roger has been Vice President of Business Evaluation & Deal Structuring at Takeda Pharmaceutical and Nycomed and Global Brand Manager Symbicort at AstraZeneca.
“Roger brings a lot of valuable experience and knowledge from international business development. I look forward to working together with Roger to develop the commercial part of the business,” says Orest Lastow, CEO.